Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
JNK1 and JNK2 are members of the c-Jun N-terminal kinase (JNK) family, which belong to the mitogen-activated protein kinase (MAPK) superfamily. These kinases are serine/threonine protein kinases that play crucial roles in transducing signals from various extracellular stimuli to regulate gene expression, cellular proliferation, differentiation, survival, apoptosis, immune responses, and stress responses. They are activated by dual phosphorylation on threonine and tyrosine residues within a TPY motif, primarily by upstream kinases MKK4/7. JNKs regulate apoptosis, cell proliferation/differentiation, and autophagy. They are implicated in various diseases, including cancer, neurodegeneration, and inflammation.
Kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on c-Jun N-terminal Kinases 1 and 2 (JNK 1/2).